MedTrace Logo

Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome

NCT00277563 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-09-21

No results posted yet for this study

Summary

Pulsed electromagnetic fields (PEMF) have been approved by FDA and are utilized currently in treating non-union fractures, neurogenic bladder and musculoskeletal pains. Based on 2 prior pilot studies (open label) demonstrating reduction in neuropathic pain from carpal tunnel syndrome we decided to perform a placebo-controlled trial, randomized for 2 months utilizing a wrist PEMF device attached by Velcro for 4 hours/day.

Conditions

  • Refractory Carpal Tunnel Syndrome
  • Neurpathic Pain
  • Neuromodulaton

Interventions

DEVICE

reduction of pain scores by magnetic energy

Sponsors & Collaborators

  • Dr. Steven P. Cole, PhD. Statistician

    collaborator UNKNOWN

  • Weintraub, Michael I., MD, FACP, FAAN

    lead INDIV

Principal Investigators

  • Steven P. Cole, PhD · Statistician

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2005-07-31

Countries

  • United States

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00277563 on ClinicalTrials.gov